First Quadrant’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
First Quadrant's IDXX Position: Q1 2022 in Review
First Quadrant sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 6,191 shares — an estimated $4.08M sold.
First Quadrant first reported a position in IDXX in Q3 2016 and held it in 22 quarters. The position peaked at $34.7M in Q1 2017. 1,033 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.
- First Quadrant reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
- First Quadrant sold 6,191 Idexx Laboratories shares in Q1 2022, an estimated $4.08M.
- First Quadrant first reported a position in Idexx Laboratories in Q3 2016 and held it in 22 quarters.
- First Quadrant's Idexx Laboratories position peaked at $34.7M in Q1 2017.
- 1,033 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.
Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.